Skip to main content
Journal cover image

Movement Disorder Society-Unified Parkinson's Disease Rating Scale Use in the Covid-19 Era.

Publication ,  Journal Article
Goetz, CG; Stebbins, GT; Luo, S
Published in: Mov Disord
June 2020

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Mov Disord

DOI

EISSN

1531-8257

Publication Date

June 2020

Volume

35

Issue

6

Start / End Page

911

Location

United States

Related Subject Headings

  • SARS-CoV-2
  • Pneumonia, Viral
  • Pandemics
  • Neurology & Neurosurgery
  • Movement Disorders
  • Mental Status and Dementia Tests
  • Humans
  • Coronavirus Infections
  • COVID-19
  • Betacoronavirus
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Goetz, C. G., Stebbins, G. T., & Luo, S. (2020). Movement Disorder Society-Unified Parkinson's Disease Rating Scale Use in the Covid-19 Era. Mov Disord, 35(6), 911. https://doi.org/10.1002/mds.28094
Goetz, Christopher G., Glenn T. Stebbins, and Sheng Luo. “Movement Disorder Society-Unified Parkinson's Disease Rating Scale Use in the Covid-19 Era.Mov Disord 35, no. 6 (June 2020): 911. https://doi.org/10.1002/mds.28094.
Goetz CG, Stebbins GT, Luo S. Movement Disorder Society-Unified Parkinson's Disease Rating Scale Use in the Covid-19 Era. Mov Disord. 2020 Jun;35(6):911.
Goetz, Christopher G., et al. “Movement Disorder Society-Unified Parkinson's Disease Rating Scale Use in the Covid-19 Era.Mov Disord, vol. 35, no. 6, June 2020, p. 911. Pubmed, doi:10.1002/mds.28094.
Goetz CG, Stebbins GT, Luo S. Movement Disorder Society-Unified Parkinson's Disease Rating Scale Use in the Covid-19 Era. Mov Disord. 2020 Jun;35(6):911.
Journal cover image

Published In

Mov Disord

DOI

EISSN

1531-8257

Publication Date

June 2020

Volume

35

Issue

6

Start / End Page

911

Location

United States

Related Subject Headings

  • SARS-CoV-2
  • Pneumonia, Viral
  • Pandemics
  • Neurology & Neurosurgery
  • Movement Disorders
  • Mental Status and Dementia Tests
  • Humans
  • Coronavirus Infections
  • COVID-19
  • Betacoronavirus